NCT05202912View on ClinicalTrials.gov

Food Effect Study of IDX-1197 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

January 16, 2022

Primary Completion Date

July 23, 2022

Study Completion Date

July 23, 2022

Conditions
Healthy Male
Interventions
DRUG

IDX-1197(After a meal)

randomized, open-label, single-dose, 2-period, 2-sequence crossover study in healthy male Korean and Caucasian volunteers

DRUG

IDX-1197(fasting)

open-label, single-dose study in Chinese male volunteers

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Idience Co., Ltd.

INDUSTRY